SCHEMBL7645110

SCHEMBL7645110

COc1ccc(-c2cc3ccc(OC(C)=O)cc3s2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.54
HDAC6 Q9UBN7 2/20 0.53
ALDH1A1 P00352 3/20 0.50
HPGD P15428 3/20 0.50
NPC1 O15118 2/20 0.50
TP53 P04637 2/20 0.50
MAPT P10636 2/20 0.50
RAB9A P51151 2/20 0.50
HSD17B10 Q99714 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
ALOX15 P16050 1/20 0.50
TSHR P16473 1/20 0.50
NFKB1 P19838 1/20 0.50
MAPK1 P28482 1/20 0.50
NFKB2 Q00653 1/20 0.50
RELA Q04206 1/20 0.50
BACE1 P56817 2/20 0.49
IKBKB O14920 2/20 0.48
ESR1 P03372 2/20 0.45
ESR2 Q92731 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7636676 0.94 CA2 (0.51) CA2HDAC6ALDH1A1HPGDNPC1
SCHEMBL2561003 0.93 CA2 (0.58) CA2HDAC6MAPTHSD17B10ESR1
SCHEMBL7641278 0.89 ESR1 (0.60) CA2HDAC6ESR1ESR2APP
SCHEMBL7642201 0.87 CA2 (0.56) CA2ALDH1A1NPC1MAPTRAB9A
SCHEMBL20312064 0.87 HDAC6 (0.49) CA2HDAC6ALDH1A1HPGDNPC1
SCHEMBL1665299 0.85 NPC1 (0.56) CA2HDAC6ALDH1A1HPGDNPC1
SCHEMBL31310542 0.85 NPC1 (0.56) CA2HDAC6ALDH1A1HPGDNPC1
SCHEMBL21470083 0.84 CA2 (0.53) CA2HDAC6MAPTHSD17B10ESR1
SCHEMBL7636669 0.84 HDAC6 (0.50) CA2HDAC6ALDH1A1HPGDNPC1
SCHEMBL7642766 0.83 ESR1 (0.65) CA2HDAC6HSD17B10ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6395769-B1 ACTIVATION ESTROGEN; THERAPY FOR OSTEOPOROSIS, ANTILIPEMIC AGENTS ELI LILLY AND COMPANY 2002-05-28 US claimed
US-6096781-A 2-PHENYL-1-BENZOTHIOPHENE DERIVATIVES ARE USEFUL FOR TREATMENT OF OSTEOPOROSIS AND HYPERLIPEMIA ELI LILLY AND COMPANY (US) 2000-08-01 US claimed
EP-0920862-A1 2-Arylbenzo b thiophenes useful for the treatment of estrogen deprivation syndrome ELI LILLY AND COMPANY (US) 1999-06-09 EP claimed
WO-1999025707-A1 2-ARYLBENZO[b]THIOPHENES USEFUL FOR THE TREATMENT OF ESTROGEN DEPRIVATION SYNDROME ELI LILLY AND COMPANY (US) 1999-05-27 WO claimed
US-6395769-B1 ACTIVATION ESTROGEN; THERAPY FOR OSTEOPOROSIS, ANTILIPEMIC AGENTS ELI LILLY AND COMPANY 2002-05-28 US disclosed
US-6096781-A 2-PHENYL-1-BENZOTHIOPHENE DERIVATIVES ARE USEFUL FOR TREATMENT OF OSTEOPOROSIS AND HYPERLIPEMIA ELI LILLY AND COMPANY (US) 2000-08-01 US disclosed
EP-0920862-A1 2-Arylbenzo b thiophenes useful for the treatment of estrogen deprivation syndrome ELI LILLY AND COMPANY (US) 1999-06-09 EP disclosed